Watchman FLX™ left atrial appendage closure device

BRIEF PROFILE
reg.: n/a
register now
01 application implant with delivery system,  left atrial appendage closure device with delivery system, permanently implanted, intended to prevent blood clots in the left atrial appendage (LAA) from entering the bloodstream™
02 specific this approval expands the indications to include the use of these devices in patients who have non-valvular atrial fibrillation, are at increased risk for stroke, are recommended and suitable for blood thining medication (anticoagulation therapy), and have an appropriate reason to seek a non-drug alternative to anticoagulation therapy
03 company Boston Scientific Corp.
04 illustration
the implant
05 material nitinol (titanium, nickel)
06 approvals n/a CE Marking X FDA Approval
n/a ISO n/a DIN
n/a n/a
07 regional contacts n/a
08 last update 2020 11 13
not registered / this page is not approved by the provider
This “Brief Profile” shows a nonregistered implant. Information given here are checked thoroughly by “Implant-Register”. Illustrations refer to the company, if not shown differently. However we can not guarantee for any material or properties. Ask the manufacturer for such questions and give us the information to improve the Register. If there are pictures like logos or implants, they are taken from the companies website. The publishing company may inform us to hide them.
No comments yet. You are welcome to send comments here.